Please use this identifier to cite or link to this item:
https://hdl.handle.net/1959.11/63632
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rowe, Christopher W | en |
dc.contributor.author | Watkins, Brendan | en |
dc.contributor.author | Brown, Karina | en |
dc.contributor.author | Delbridge, Matthew | en |
dc.contributor.author | Addley, Jordan | en |
dc.contributor.author | Woods, Andrew | en |
dc.contributor.author | Wynne, Katie | en |
dc.date.accessioned | 2024-10-22T05:20:05Z | - |
dc.date.available | 2024-10-22T05:20:05Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Diabetic Medicine, 38(4), p. 1-12 | en |
dc.identifier.issn | 1464-5491 | en |
dc.identifier.issn | 0742-3071 | en |
dc.identifier.uri | https://hdl.handle.net/1959.11/63632 | - |
dc.description.abstract | <p><b>Aims:</b> Hyperglycaemia following antenatal corticosteroids is common in womenwith diabetes in pregnancy, and validated algorithms to maintain pregnancy-specificglucose targets are lacking. The Pregnancy-IVI, an intravenous-insulin (IVI) algo-rithm, has been validated in gestational diabetes" however, its performance in pre-existing diabetes (Type 1 and Type 2 diabetes) is not known. We hypothesised that Pregnancy-IVI would be superior to a generic Adult-IVI protocol (prior standard of care) following betamethasone in women with pre-existing diabetes.</p><p><b>Methods:</b> A retrospective cohort study enrolled all women with pre-existing diabetes at a tertiary centre receiving betamethasone and treated with IVI according to one of two protocols: Adult-IVI (n = 73, 2014–2017) or Pregnancy-IVI (n = 62,2017–2020). The primary outcome was on-IVI glycaemic time-in-range (capillary blood glucose (BGL) 3.8–7.0 mmol/L). Secondary outcomes included time with critical hyperglycaemia (BGL > 10 mmol/L)" occurrence of maternal hypoglycaemia (BGL < 3.8 mmol/l) and incidence of neonatal hypoglycaemia (BGL ≤ 2.5 mmol/L).Analysis was stratified by diabetes type.</p><p><b>Results:</b> Overall, Pregnancy-IVI achieved a higher proportion of on-IVI time-in-range (70%, IQR 56–78%) compared to Adult-IVI (52%, IQR 41–69%, p < 0.0001).The duration of critical hyperglycaemia with Pregnancy-IVI was also reduced (2%[IQR 0–7] vs 8% [IQR 4–17], p < 0.0001), without an increase in hypoglycaemia. Glycaemic variability was significantly reduced with Pregnancy-IVI. No difference in the rate of neonatal hypoglycaemia was observed. The Pregnancy-IVI was most effective in women with Type 1 diabetes.</p><p><b>Conclusion:</b> The Pregnancy-IVI algorithm is safe and effective when used following betamethasone in type 1 diabetes in pregnancy. Further study of women with type 2diabetes is required.</p> | en |
dc.language | en | en |
dc.publisher | Wiley-Blackwell Publishing Ltd | en |
dc.relation.ispartof | Diabetic Medicine | en |
dc.title | Efficacy and safety of the pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in type 1 and type 2 diabetes | en |
dc.type | Journal Article | en |
dc.identifier.doi | 10.1111/dme.14489 | en |
dc.subject.keywords | insulin therapy | en |
dc.subject.keywords | pregnancy | en |
dc.subject.keywords | Endocrinology & Metabolism | en |
dc.subject.keywords | patient diabetes | en |
dc.subject.keywords | in‐ | en |
local.contributor.firstname | Christopher W | en |
local.contributor.firstname | Brendan | en |
local.contributor.firstname | Karina | en |
local.contributor.firstname | Matthew | en |
local.contributor.firstname | Jordan | en |
local.contributor.firstname | Andrew | en |
local.contributor.firstname | Katie | en |
local.profile.school | School of Rural Medicine | en |
local.profile.email | bwatkin6@une.edu.au | en |
local.output.category | C1 | en |
local.record.place | au | en |
local.record.institution | University of New England | en |
local.publisher.place | United Kingdom | en |
local.identifier.runningnumber | e14489 | en |
local.format.startpage | 1 | en |
local.format.endpage | 12 | en |
local.peerreviewed | Yes | en |
local.identifier.volume | 38 | en |
local.identifier.issue | 4 | en |
local.contributor.lastname | Rowe | en |
local.contributor.lastname | Watkins | en |
local.contributor.lastname | Brown | en |
local.contributor.lastname | Delbridge | en |
local.contributor.lastname | Addley | en |
local.contributor.lastname | Woods | en |
local.contributor.lastname | Wynne | en |
dc.identifier.staff | une-id:bwatkin6 | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.identifier.unepublicationid | une:1959.11/63632 | en |
local.date.onlineversion | 2021 | - |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
local.title.maintitle | Efficacy and safety of the pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in type 1 and type 2 diabetes | en |
local.output.categorydescription | C1 Refereed Article in a Scholarly Journal | en |
local.search.author | Rowe, Christopher W | en |
local.search.author | Watkins, Brendan | en |
local.search.author | Brown, Karina | en |
local.search.author | Delbridge, Matthew | en |
local.search.author | Addley, Jordan | en |
local.search.author | Woods, Andrew | en |
local.search.author | Wynne, Katie | en |
local.uneassociation | Yes | en |
local.atsiresearch | No | en |
local.sensitive.cultural | No | en |
local.year.available | 2021 | en |
local.year.published | 2021 | en |
local.fileurl.closedpublished | https://rune.une.edu.au/web/retrieve/2308ae1c-91d8-47c9-b8e0-ef9fe14dd145 | en |
local.subject.for2020 | 3202 Clinical sciences | en |
local.subject.seo2020 | tbd | en |
local.profile.affiliationtype | External Affiliation | en |
local.profile.affiliationtype | UNE Affiliation | en |
local.profile.affiliationtype | UNE Affiliation | en |
local.profile.affiliationtype | UNE Affiliation | en |
local.profile.affiliationtype | External Affiliation | en |
local.profile.affiliationtype | External Affiliation | en |
local.profile.affiliationtype | External Affiliation | en |
Appears in Collections: | Journal Article School of Science and Technology |
Files in This Item:
File | Size | Format |
---|
Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.